Teva Pharmaceutical Industries Limited Tangible Net Worth Ratio
Teva Pharmaceutical Industries Limited tangible net worth ratio. Teva Pharmaceutical Industries Limited (TEV) has a Tangible Net Worth Ratio of 56.2% as of March 2026. This metric is calculated by deducting intangible assets (€3.61 Billion) from net assets (€8.23 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Teva Pharmaceutical Industries Limited equity growth rate to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Teva Pharmaceutical Industries Limited (2015–2025)
Tangible net worth ratio of Teva Pharmaceutical Industries Limited from 2015 to 2025. This chart shows how Teva Pharmaceutical Industries Limited's Tangible Net Worth Ratio has changed across 11 annual periods from 2015 to 2025. As of March 2026, the ratio stands at 56.2%, reflecting net assets of €8.23 Billion with intangible assets of €3.61 Billion EUR. Check how strategically is Teva Pharmaceutical Industries Limited's equity deployed to assess the company's strategic physical and investment asset allocation.
Teva Pharmaceutical Industries Limited Tangible Net Worth Ratio by Year (2015–2025)
Teva Pharmaceutical Industries Limited tangible net worth ratio by year from 2015 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Teva Pharmaceutical Industries Limited from 2015 to 2025, covering 11 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see Teva Pharmaceutical Industries Limited market cap and net worth.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 52.2% | €7.91 Billion | €3.78 Billion | €40.75 Billion | ▲ +29.5 pp |
| 2024 | 22.8% | €5.72 Billion | €4.42 Billion | €39.33 Billion | ▼ -10.9 pp |
| 2023 | 33.7% | €8.13 Billion | €5.39 Billion | €43.48 Billion | ▲ +5.9 pp |
| 2022 | 27.9% | €8.69 Billion | €6.27 Billion | €44.01 Billion | ▼ -5.7 pp |
| 2021 | 33.6% | €11.24 Billion | €7.47 Billion | €47.67 Billion | ▲ +14.3 pp |
| 2020 | 19.3% | €11.06 Billion | €8.92 Billion | €50.64 Billion | ▼ -6.1 pp |
| 2019 | 25.4% | €15.06 Billion | €11.23 Billion | €57.47 Billion | ▲ +14.1 pp |
| 2018 | 11.3% | €15.79 Billion | €14.01 Billion | €60.68 Billion | ▲ +5.4 pp |
| 2017 | 5.9% | €18.75 Billion | €17.64 Billion | €70.61 Billion | ▼ -32.7 pp |
| 2016 | 38.6% | €34.99 Billion | €21.49 Billion | €92.89 Billion | ▼ -35.8 pp |
| 2015 | 74.4% | €29.93 Billion | €7.67 Billion | €54.23 Billion | — |